KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Assets (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Other Non-Current Assets data on record, last reported at $4.2 million in Q3 2025.

  • For Q3 2025, Other Non-Current Assets fell 73.23% year-over-year to $4.2 million; the TTM value through Sep 2025 reached $4.2 million, down 73.23%, while the annual FY2024 figure was $15.6 million, 88.61% down from the prior year.
  • Other Non-Current Assets reached $4.2 million in Q3 2025 per SRPT's latest filing, down from $7.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $293.1 million in Q3 2022 and bottomed at $3.9 million in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $61.5 million, with a median of $15.6 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: grew 13.7% in 2021, then tumbled 88.61% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.9 million in 2021, then surged by 7493.89% to $293.1 million in 2022, then plummeted by 53.34% to $136.8 million in 2023, then crashed by 88.61% to $15.6 million in 2024, then tumbled by 73.23% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $4.2 million in Q3 2025, $7.4 million in Q2 2025, and $15.6 million in Q4 2024.